top of page
Corvidane is developing Corvida™ for FDA drug approval to prevent the two leading causes of death worldwide and the leading cause of liver transplants in the United States.
Corvida™ uses Omega-7 and Omega-9 fatty acids for their ability to improve lipid metabolism and their anti-inflammatory properties. This potential is used to target diseases of lipid metabolism and inflammation such as Atherosclerosis and NAFLD/NASH.
bottom of page